A carregar...
Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
Considerable progress has been made in treatments for multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) over the last several decades. However, the present treatments do not show satisfactory efficacy or safety in a considerable proportion of patients, who experience relapse...
Na minha lista:
| Publicado no: | J Clin Neurol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Neurological Association
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7354979/ https://ncbi.nlm.nih.gov/pubmed/32657055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3988/jcn.2020.16.3.355 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|